Trials / Completed
CompletedNCT06383494
GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I)
GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management Under General Anesthesia, a Randomized Controlled Study (GLAM-I)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 498 (actual)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients were randomly assigned to three supraglottic airway devices (SADs) groups for airway management after anesthesia induced. Fiberoptic bronchoscope (FB) guided glottic exposure grading was performed and other airway management quality was recorded.
Detailed description
Mechanical ventilation was volume controlled and time cycled with tidal volumes (6-8 ml/kg) set to maintain peak inspiratory pressures of less than 20 cm H2O and ventilatory frequency adjusted to maintain end-tidal carbon dioxide (PETCO2) at 35-45 mmHg. Then a fiberoptic bronchoscope was passed through airway tube into the device to perform glottic exposure grading. Peak airway pressure, incidence of pharyngalgia, bleeding, hoarseness, and dysphagia were recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LMA supreme group | Patient in this group received LMA supreme (one of laryngeal airway management device) for airway management during general anesthesia |
| DEVICE | I-gel group | Patient in this group received I-gel laryngeal (one of laryngeal airway management device) for airway management during general anesthesia |
| DEVICE | GMA-Tulip | Patient in this group received GMA-Tulip (one of laryngeal airway management device) for airway management during general anesthesia |
Timeline
- Start date
- 2024-04-30
- Primary completion
- 2024-12-31
- Completion
- 2025-01-01
- First posted
- 2024-04-25
- Last updated
- 2026-01-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06383494. Inclusion in this directory is not an endorsement.